Cargando…
Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
Background: Immune checkpoint inhibitors (ICIs) emerged as the preferred therapy in advanced lung cancer, understanding the treatment- and immune-related adverse events of these drugs is of great significance for clinical practice. Materials and methods: PubMed, Embase, Cochrane library and major co...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953488/ https://www.ncbi.nlm.nih.gov/pubmed/32315071 http://dx.doi.org/10.1042/BSR20192347 |